2012
DOI: 10.1371/journal.pone.0053569
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein E4 Causes Age- and Sex-Dependent Impairments of Hilar GABAergic Interneurons and Learning and Memory Deficits in Mice

Abstract: Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease (AD). ApoE4 has sex-dependent effects, whereby the risk of developing AD is higher in apoE4-expressing females than males. However, the mechanism underlying the sex difference, in relation to apoE4, is unknown. Previous findings indicate that apoE4 causes age-dependent impairments of hilar GABAergic interneurons in female mice, leading to learning and memory deficits. Here, we investigate whether the detrimental effects of apoE4 o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
80
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 87 publications
(85 citation statements)
references
References 98 publications
5
80
0
Order By: Relevance
“…In all figures white bars represent C57BL/6J and black bars represent Arg-61 mice. the female mice, in line with the greater risk in women to develop AD and an apparently greater effect of apoE4 in impairing spatial memory performance in females (32,63,64). This observation is consistent with numerous studies in apoE4 subjects showing that the role of apoE4 in cognitive function extends beyond the AD disease state, which apoE4 gene clearly impacts.…”
Section: Discussionsupporting
confidence: 88%
“…In all figures white bars represent C57BL/6J and black bars represent Arg-61 mice. the female mice, in line with the greater risk in women to develop AD and an apparently greater effect of apoE4 in impairing spatial memory performance in females (32,63,64). This observation is consistent with numerous studies in apoE4 subjects showing that the role of apoE4 in cognitive function extends beyond the AD disease state, which apoE4 gene clearly impacts.…”
Section: Discussionsupporting
confidence: 88%
“…ApoE4 knock-in mice show an age-dependent decrease in hilar GABAergic interneurons, which correlates with the extent of apoE4-induced impairments of adult hippocampal neurogenesis and with learning and memory deficits (Andrews-Zwilling et al, 2010; Leung et al, 2012; Li et al, 2009). In transgenic mice expressing neurotoxic apoE4 fragments, the loss of hilar interneurons is more pronounced and also correlates with learning and memory deficits (Andrews-Zwilling et al, 2010).…”
Section: Aβ-independent Effects Of Apoe4 On Ad Pathogenesismentioning
confidence: 98%
“…Morphological studies of these transgenic mouse lines demonstrated that human apoE3 prevents the age-dependent neurodegeneration seen in apoE-null mice and prevents kainic acid–induced neurodegeneration; human apoE4 is not protective (Buttini et al, 1999). ApoE4 knock-in mice also show age- and sex-dependent impairment of spatial learning and memory (Andrews-Zwilling et al, 2010; Leung et al, 2012). Transgenic mice expressing apoE4 in astrocytes had impairment of working memory, although no significant neuropathological changes were found in the brains of these mice (Hartman et al, 2001).…”
Section: Aβ-independent Effects Of Apoe4 On Ad Pathogenesismentioning
confidence: 99%
“…Furthermore, decreases in GABA and SST levels are more pronounced in apoE4 carriers (accounting for 60-75% of AD patients) exhibiting enhanced brain activity at rest and in response to memory tasks (Grouselle et al, 1998;Filippini et al, 2009;Dennis et al, 2010). Moreover, the expression of apoE4 in mice causes an age-and sex-dependent (female>-male) decrease in hilar GABAergic interneurons, which correlates with the severity of learning and memory deficits (Andrews-Zwilling et al, 2010; Leung et al, 2012). Likewise, increased production or aggregation of Aβ interferes with interneuron function and leads to abnormal DG activity and cognitive impairments (Verret et al, 2012).…”
Section: Promise Of Gaba-ergic Cell Therapy For Alzheimer's Diseasementioning
confidence: 99%